Cutaneous Melanoma Active Not Recruiting Phase 1 Trials for Merestinib (DB12381)

IndicationStatusPhase
DBCOND0040978 (Cutaneous Melanoma)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02791334A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid TumorsTreatment